Synthetic Antiferromagnetic Designer Nanodisks for High‐Performance Magnetic Separation
Magnetic separation of magnetic particles offers an appealing route to rapid and selective target capturing and isolation. However, to leverage such an approach to its full potential, high colloidal stability of the nanoparticles in the absence of a magnetic field for optimal binding, and rapid and quantitative recovery upon magnetic gradient field application are imperative. While these properties are mutually exclusive for conventional nanoparticles synthesized by wet-chemistry approaches, sputter deposition gives access to layered architectures featuring the properties of a synthetic antiferromagnet (SAF, no magnetization in zero field, high magnetization upon field application). Here, micromagnetic-modelling based design optimization and scalable manufacturing of metallic CoSm-based, metal oxide-capped SAF magnetic disk particles (SAF MDPs) with high chemical and colloidal stability and cytocompatibility are presented. It is demonstrated that the SAF MDPs can be rapidly and much more efficiently separated ( <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mo>></mml:mo> <mml:mn>99</mml:mn> <mml:mo>%</mml:mo></mml:mrow> <mml:annotation>$>99\%$</mml:annotation></mml:semantics> </mml:math> ) from flowing fluids (approx. 1 mL/min) compared to corresponding gold standard iron oxide beads ( <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mn>60</mml:mn> <mml:mo>%</mml:mo></mml:mrow> <mml:annotation>$60\%$</mml:annotation></mml:semantics> </mml:math> recovery), paving the way to quantitative capturing and enrichment of target compounds in high-throughput conditions compliant with clinical and industrial applications.
Authors
- Anna L. Neuer (ORCID: https://orcid.org/0000-0002-5762-4709)
- Sebastian Habermann (ORCID: https://orcid.org/0000-0003-4060-846X)
- Subas Scheibler (ORCID: https://orcid.org/0000-0003-0425-0026)
- Santiago Helbig (ORCID: https://orcid.org/0000-0002-4034-8883)
- Michał Krupiński (ORCID: https://orcid.org/0000-0003-2984-2052)
- Hans J. Hug (ORCID: https://orcid.org/0000-0002-1281-4138)
- Mohammad Alinezhadfar (ORCID: https://orcid.org/0000-0002-2449-5066)
- Vera M. Kissling (ORCID: https://orcid.org/0000-0002-4524-9905)
- Rowena Crockett (ORCID: https://orcid.org/0000-0001-9006-9500)
- Nico Kummer (ORCID: https://orcid.org/0000-0002-0366-5767)
- Alexander Gogos (ORCID: https://orcid.org/0000-0001-6233-512X)
- Lukas R. H. Gerken (ORCID: https://orcid.org/0000-0002-8568-2674)
- Dieter Süss
- E. Mayr (ORCID: https://orcid.org/0009-0009-4217-9938)
- I. F. Herrmann (ORCID: https://orcid.org/0009-0006-4655-6807)
Institutions
- University of Vienna (AT)
- University of Basel (CH)
- University of Zurich (CH)
- ETH Zurich (CH)
- Institute for Biomedical Engineering (CH)
- Institute of Nuclear Physics, Polish Academy of Sciences (PL)
- Universitätsklinik Balgrist (CH)
- Swiss Federal Laboratories for Materials Science and Technology (CH)
Publication Details
- Journal
- Advanced Healthcare Materials
- Published
- 2025-08-11
- DOI
- https://doi.org/10.1002/adhm.202500616
- Citations
- 1
- Primary Topic
- ZnO doping and properties
- Type
- article
- Field-Weighted Citation Impact
- 0.52
Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Eidgenössische Technische Hochschule Zürich